Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

A randomized controlled evaluation of absorption of silver with the use of silver alginate (Algidex) patches in very low birth weight (VLBW) infants with central lines

Journal of Perinatology volume 30, pages 337–342 (2010)Cite this article

Abstract

Objective:

To measure systemic silver absorption when using silver-impregnated alginate central catheter dressings in very low birth weight (VLBW) neonates and to monitor blood stream infection.

Study Design:

Fifty infants were enrolled in a prospective, randomized controlled trial lasting 28 days. Each patient was assigned to standard dressing or silver alginate (Algidex) group. Serum silver concentrations were obtained on day 1, 7, and 28.

Result:

Significant differences in mean serum silver concentrations for the treatment versus standard dressing group were observed using student’s t-test analysis. The silver alginate group had a 45.8% reduction in infection/1000 line days, although too few patients were enrolled to draw meaningful efficacy conclusions about prevention of blood stream infection.

Conclusion:

Mean serum silver concentrations in the treatment group were significantly higher than controls although below levels anticipated to result in toxicity. A large study evaluating reduced blood stream infections in VLBW infants is warranted.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Elliott TSJ . Role of antimicrobial central venous catheters for prevention of associated infections. J Antimicrobl Chemother 1999; 43: 441–446.

    Article  CAS  Google Scholar 

  2. Roe D, Karaandikar B, Bonn-Savage N, Gibbons B, Roullet J . Antimicrobial surface functionalization of plastic catheters by silver nanoparticles. J Anitimicrob Chemother 2008; 61: 869–876.

    Article  CAS  Google Scholar 

  3. Madeo M, Martin CR, Turner C, Kirkby V, Thompson DR . A randomized trial comparing Arglaes (a transparent polyurethane dressing) toTegaderm (a transparent polyurethane dressing) for dressing peripheral arterial catheters and central venous catheters. Intensive Crit Care Nurs 1998; 14: 187–191.

    Article  CAS  Google Scholar 

  4. Meaume S, Vallet D, Morere MN, Teot L . Evaluation of a silver-releasing hydroalginate dressing in chronic wounds with signs of local infection. J Wound Care 2005; 14: 411–419.

    Article  CAS  Google Scholar 

  5. Algidex (package insert). Powell: DeRoyal 2005.

  6. Mayo Clinic Reference laboratory 2005, http://www.mayomedicallaboratories.com/test-catalog/Clinical+and+interpretive/8607 Imbedded references: a. Seller HG, Sigel A, Sigel H. Handbook on Metals in Clinical and Analytical Chemistry. Marcel Dekkter, Inc: New York 1994 b. Coombs, CJ, Wan AT, Masterson JP et al. ‘Do burn Patients have a silver lining?’ Burns 199218: 179–184.

  7. Fung M, Bowen D . Silver products for medical indications: risk benefit assessment. Clin Toxicol 1996; 34: 119–126.

    CAS  Google Scholar 

  8. Rustogi R, Mill J, Fraser JF, Kimble RM . The Use of Acticoat in Neonatal Burns. Burns 2005; 31: 878–882.

    Article  CAS  Google Scholar 

  9. Williams N, Gardner I . Absence of symptoms in silver refiners with raised blood silver concentrations. Occup Med 1995; 45: 205–208.

    Article  CAS  Google Scholar 

  10. McIntyre E, Wilcox J, McGill J, Lewindon PJ . Silver Toxicity in an Infant of Strict Vegan Parents. J Ped Gastroent and Nut 2001; 33: 501–502.

    Article  CAS  Google Scholar 

  11. Rungy J, Danscher G . ‘Hypoactivity in sliver exposed mice’. Acta Pharmacol Toxicol 1984; 55: 398–401.

    Article  Google Scholar 

  12. CDC. (accessed 10/28/2008) Toxilogic Profile for Silver. http://www.atsdr.cdc.gov/toxprofiles/tp146.pdf.

  13. OHSA. http://www.cdc.gov/niosh/idlh/7440224.html(accessed 10/28/2008).

  14. Robkin MA, Swanson DR, Shepard TH . Trace metal concentrations in human fetal livers. Trans Am Nucl Sot 1973; 17: 97.

    Google Scholar 

  15. American Society of Health-System Pharmacists. AHFS Drug information. American Society of Health-System Pharmacists: Bethesda, MD, 1998. pp 2918–2919.

  16. Guggenbichler JP, Boswald M, Lugauer S et al. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 1999; 22: S16–S17.

    Article  Google Scholar 

  17. Yin HQ, Lanford R, Burrell RE . Comparative evaluation of the antimicrobial activity of Acticoat® antimicrobial barrier dressing. J Burn Care Rehabil 1990; 20: 195–200.

    Article  Google Scholar 

  18. Poon KM, Burd A . In vitro toxicity of silver: implication for clinical wound care. Burns 2004; 30: 140–147.

    Article  Google Scholar 

  19. Ovington LG . The truth about silver. Ostomy Wound Management 2004; 50 (9A suppl): 1s–10s.

    Google Scholar 

  20. Brooks KL, Dauenhauer SA, Evans JT Decreased incidence of Central Line Related Bloodstream infections Associated with Use of Silver-Impregnated Dressing at Central Venous Catheter Sites Presented 4 h Decennial Conf on Nosocomial and Healthcare Associated Infections Atlanta 2000 (accessed November 2008) http://www.medline.com/woundcare/products/arglaes/PDFs/Case%20Study%20-%20Arglaes-Decreased%20Incidence.pdf.

  21. Vanscheidtr W, Lazareth I, Routkovsky-Norval C . Safety evaluation of a new ionic silver dressing in the management of chronic ulcers. Wounds 2003; 15: 371–378.

    Google Scholar 

  22. Ricketts CR, Lowbury EJ, Lawrence JC, Hall M, Wilkens MD . Mechanism of prophylaxis by silver compounds against infection of burns. Br Med J 1970; 2: 444–446.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neonatology, Baylor University Medical Center, Dallas, TX, USA

    A Z Khattak, R Ross, T Ngo & C T Shoemaker

Authors
  1. A Z Khattak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R Ross
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Ngo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C T Shoemaker
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Z Khattak.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on the Journal of Perinatology website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Khattak, A., Ross, R., Ngo, T. et al. A randomized controlled evaluation of absorption of silver with the use of silver alginate (Algidex) patches in very low birth weight (VLBW) infants with central lines. J Perinatol 30, 337–342 (2010). https://doi.org/10.1038/jp.2009.169

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jp.2009.169

Keywords

This article is cited by

Search

Advanced search

Quick links